<DOC>
	<DOC>NCT00376662</DOC>
	<brief_summary>To determine and compare the effects of Hormone replacement therapy (HRT), etidronate, HRT plus etidronate and no treatment over 5 years in the prevention and treatment of glucocorticoid-induced osteoporosis and fractures in post-menopausal women with asthma.</brief_summary>
	<brief_title>HRT Versus Etidronate for Osteoporosis and Fractures in Asthmatics Receiving Glucocorticoids.</brief_title>
	<detailed_description>Multicentre trial involving 13 hospitals in United Kingdom, with patients entered by 17 Consultant Chest Physicians. Consenting patients were randomised in a central office to either HRT, etidronate, HRT plus etidronate or no treatment. Information on the progress of the patients was requested by the co-ordinating office annually for 5 years after entry to the trial. Outcomes were measured as new symptomatic fractures,new or worsening morphometric fractures of the thoraco-lumbar spine and changes in bone mineral density.</detailed_description>
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<mesh_term>Glucocorticoids</mesh_term>
	<mesh_term>Etidronic Acid</mesh_term>
	<criteria>Postmenopausal, asthmatic outpatients under 60 years of age on longterm oral or inhaled glucocorticoid treatment for at least one year. Hysterectomy, history of breast or endometrial cancer, undiagnosed pelvic or breast mass, untreated hypertension.</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>59 Years</maximum_age>
	<verification_date>September 2006</verification_date>
	<keyword>HRT</keyword>
	<keyword>Etidronate</keyword>
	<keyword>Fractures</keyword>
	<keyword>Osteoporosis</keyword>
	<keyword>Asthma</keyword>
	<keyword>Glucocorticoids</keyword>
</DOC>